HEATHER RICHARDSON: Open Payments
NPI 1558822981 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 71 payments from 13 companies in 2025. Trend: 2023 $2,529 · 2024 $2,602 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $614 |
| ABBVIE INC. | 20 | $263 |
| Janssen Pharmaceuticals, Inc | 9 | $220 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 3 | $71 |
| Lundbeck LLC | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Neos Therapeutics, LP | 3 | $48 |
Products named: COBENFY, VRAYLAR, SPRAVATO, REXULTI, FANAPT, CAPLYTA, Jornay PM, INGREZZA.
Industry payments across VA — which companies pay providers there.
